These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 7711410)

  • 1. Sustained elimination of hepatitis B virus from serum induced in a patient with chronic hepatitis B and advanced human immunodeficiency virus infection.
    Wölfel T; Schirmacher P; Schlaak J; Knolle P; Dienes HP; Dippold W; Meyer zum Büschenfelde KH; Gerken G
    Clin Investig; 1994 Dec; 72(12):1030-6. PubMed ID: 7711410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type B.
    Hadziyannis S; Bramou T; Makris A; Moussoulis G; Zignego L; Papaioannou C
    J Hepatol; 1990; 11 Suppl 1():S133-6. PubMed ID: 2079571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective trial of recombinant leucocyte interferon in chronic hepatitis B: a 10-month follow-up study.
    Coppens JP; Cornu C; Lens E; Lamy M; Geubel A
    Liver; 1989 Oct; 9(5):307-13. PubMed ID: 2685491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group.
    Chemello L; Cavalletto L; Casarin C; Bonetti P; Bernardinello E; Pontisso P; Donada C; Belussi F; Martinelli S; Alberti A
    Ann Intern Med; 1996 Jun; 124(12):1058-60. PubMed ID: 8633819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent hepatitis B virus following interferon alfa therapy and liver transplantation.
    Lavine JE; Lake JR; Ascher NL; Ferrell LD; Ganem D; Wright TL
    Gastroenterology; 1991 Jan; 100(1):263-7. PubMed ID: 1983831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of chronic hepatitis B with interferon alpha-2b].
    Baumgarten R; Müller R; Markus R; Hintsche-Kilger B; Fengler JD; Meisel H
    Gastroenterol J; 1990; 50(3):124-8. PubMed ID: 2288653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels: the role of interferon alpha 2b therapy.
    Van Thiel DH; Caraceni P; Molloy PJ; Hassanein T; Kania RJ; Gurakar A; Friedlander L
    J Hepatol; 1995 Nov; 23(5):503-8. PubMed ID: 8583136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of chronic hepatitis B and C with alpha interferon in a renal transplant patient.
    Rostaing L; Izopet J; Cisterne JM; Baron E; Rumeau JL; Chabannier MH; Duffaut M; Durand D
    Scand J Urol Nephrol; 1996 Dec; 30(6):485-7. PubMed ID: 9008030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of IgM antibodies towards an immunodominant B-cell epitope within the preS2 domain of HBV in the natural course and during combined prednisone/interferon alpha 2b treatment of chronic hepatitis B virus infection.
    Fei GZ; Sylvan SP; Hellström UB; Yao GB
    J Med Virol; 1995 Jun; 46(2):138-43. PubMed ID: 7636501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-interferon for chronic active hepatitis B in human immunodeficiency virus-infected patients.
    Zylberberg H; Jiang J; Pialoux G; Driss F; Carnot F; Dubois F; Brechot C; Berthelot P; Pol S
    Gastroenterol Clin Biol; 1996; 20(11):968-71. PubMed ID: 9119186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. INTERPRED Trial Group.
    Krogsgaard K; Marcellin P; Trepo C; Berthelot P; Sanchez-Tapias JM; Bassendine M; Tran A; Ouzan D; Ring-Larsen H; Lindberg J; Enriquez J; Benhamou JP; Bindslev N
    J Hepatol; 1996 Dec; 25(6):803-13. PubMed ID: 9007706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replication.
    Lutgehetmann M; Volzt T; Quaas A; Zankel M; Fischer C; Dandri M; Petersen J
    Antivir Ther; 2008; 13(1):57-66. PubMed ID: 18389899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant.
    Tchervenkov JI; Tector AJ; Barkun JS; Sherker A; Forbes CD; Elias N; Cantarovich M; Cleland P; Metrakos P; Meakins JL
    Ann Surg; 1997 Sep; 226(3):356-65; discussion 365-8. PubMed ID: 9339942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant alpha interferon for chronic hepatitis B in anti-HIV positive patients receiving zidovudine.
    Marcellin P; Boyer N; Colin JF; Martinot-Peignoux M; Lefort V; Matheron S; Erlinger S; Benhamou JP
    Gut; 1993; 34(2 Suppl):S106. PubMed ID: 8314471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis delta superinfection during alpha-interferon treatment for hepatitis B.
    Craxì A; Di Marco V; Bruno R; Fabiano C
    Ital J Gastroenterol; 1992 Jan; 24(1):19-20; discussion 20-1. PubMed ID: 1571575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged and high dose recombinant interferon alpha-2b alone or after prednisone priming accelerates termination of active viral replication in children with chronic hepatitis B infection.
    Vajro P; Tedesco M; Fontanella A; De Vincenzo A; Vecchione R; Ammendola R; Terracciano LM; Novissimo A; Vegnente A
    Pediatr Infect Dis J; 1996 Mar; 15(3):223-31. PubMed ID: 8852910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of acute exacerbation of chronic hepatitis B accompanied by antibody to HBeAg with remission of liver damage after long-term treatment with interferon.
    Muraoka H; Sanefuji T; Keida R; Tsuji R; Abe H; Uchimura Y; Noguchi S; Suzuki H; Sata M; Tanikawa K
    Kurume Med J; 1995; 42(4):307-11. PubMed ID: 8667603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis.
    Wong DK; Cheung AM; O'Rourke K; Naylor CD; Detsky AS; Heathcote J
    Ann Intern Med; 1993 Aug; 119(4):312-23. PubMed ID: 8328741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short report: prednisolone withdrawal followed by lymphoblastoid interferon in the therapy of adult patients with presumed childhood-acquired chronic hepatitis B virus infection.
    Brook MG; Main J; Yap I; Chan G; Karayiannis P; Crossey M; Thomas HC
    Aliment Pharmacol Ther; 1993 Jun; 7(3):331-6. PubMed ID: 8364139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus.
    Marinos G; Torre F; Chokshi S; Hussain M; Clarke BE; Rowlands DJ; Eddleston AL; Naoumov NV; Williams R
    Hepatology; 1995 Oct; 22(4 Pt 1):1040-9. PubMed ID: 7557849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.